Article
NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.
Pharmacogenetics - 1 Jul 2003
van der Hel Olga L, Peeters Petra H M, Hein David W, Doll Mark A, Grobbee Diederick E, Kromhout Daan, Bueno de Mesquita H Bas
Abstract excerpt
N-acetyltransferase (NAT) 1 and 2 and glutathione S-transferase (GST) M1 and T1 are phase II enzymes that are important for activation and detoxification of carcinogenic heterocyclic and aromatic amines, as present in cigarette smoke. We studied whether genetic polymorphisms in these genes modifies the relationship between smoking and breast cancer. A nested case-control study was conducted among participants in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
